DanielWarnellLeeIIIMD

PubMed

• Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
  Archana Thakur, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Qin Liu, Maxim Yankelevich, Shakeel Modak, Daniel W L...> ;Journal for Immunotherapy of Cancer. 2024 Mar 21
• Intrathecal hydrocortisone for treatment of children and young adults with CAR T-cell immune-effector cell-associated neurotoxicity syndrome.
  Haneen Shalabi, Cynthia Harrison, Bonnie Yates, Katherine R Calvo, Daniel W Lee, Nirali N Shah> ;Pediatric Blood & Cancer. 2024 Jan 1
• A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials.
  Sara K Silbert, Sanna Madan, Elizabeth M Holland, Seth M Steinberg, Lauren Little, Toni Foley, Monica Epstein, Angela Sarkisian, Daniel W Lee, Ekaterina Nikitina, Show...> ;Blood Advances. 2023 Sep 26
• 2 citations
  A U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma.
  Daniel Lee, Haley Gittleman, Chana Weinstock, Daniel Suzman, Erik Bloomquist, Sundeep Agrawal, Michael Brave, Jamie Brewer, Jaleh Fallah, Harpreet Singh, Shenghui Tang...> ;European Urology. 2023 Oct 1
• 10 citations
  Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.
  Alan S Wayne, Van Huynh, Nobuko Hijiya, Rayne H Rouce, Patrick A Brown, Joerg Krueger, Carrie L Kitko, Edward Dela Ziga, Michelle L Hermiston, Michael K Richards, Andr...> ;Haematologica. 2023 Mar 1
• 48 citations
  Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
  Adam J Lamble, Regina M Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M Steinberg, Jennifer Sheppard, Alexandra E Kovach, Brent Wood, Michael J Borowitz, ...> ;Blood Advances. 2023 Feb 28
• 8 citations
  The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes.
  Aiman J Faruqi, John A Ligon, Paul Borgman, Seth M Steinberg, Toni Foley, Lauren Little, Crystal L Mackall, Daniel W Lee, Terry J Fry, Haneen Shalabi, Jennifer Brudno,...> ;Blood Advances. 2022 Dec 13
• 6 citations
  Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
  Emily M Hsieh, Regina M Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W Le...> ;Blood Advances. 2022 Sep 13
• 4 citations
  Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies.
  Haneen Shalabi, Staci Martin, Bonnie Yates, Pamela L Wolters, Claire Kaplan, Hannah Smith, Christopher R Sesi, Jennifer Jess, Mary Anne Toledo-Tamula, Kari Struemph, C...> ;Neuro-Oncology. 2022 Sep 1
• 48 citations
  CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
  Haneen Shalabi, Haiying Qin, Angela Su, Bonnie Yates, Pamela L Wolters, Seth M Steinberg, John A Ligon, Sara Silbert, Kniya DéDé, Mehdi Benzaoui, Sophia Goldberg, Soor...> ;Blood. 2022 Aug 4
• 23 citations
  Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.
  Holland, E., Molina, J., Dede, K., Moyer, D., Zhou, T., Yuan, C., Wang, H., Stetler-Stevenson, M., Mackall, C., Fry, T., Panch, S., Highfill, S., Stroncek, D., Little,...> ;Journal for Immunotherapy of Cancer. 2022 May 1
• 23 citations
  Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.
  Elizabeth M Holland, Bonnie Yates, Alex Ling, Constance M Yuan, Hao-Wei Wang, Maryalice Stetler-Stevenson, Michael LaLoggia, John C Molina, Daniel A Lichtenstein, Dani...> ;Blood Advances. 2022 Apr 12
• 24 citations
  Targeting of the alphabetaintegrin complex by CAR-T cells leads to rapid regression of diffuse intrinsic pontine glioma and glioblastoma.
  Dustin A Cobb, Jacopo de Rossi, Lixia Liu, Erin An, Daniel W Lee> ;Journal for Immunotherapy of Cancer. 2022 Feb 1
• 84 citations
  Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
  Regina M. Myers, Agne Taraseviciute, Seth M. Steinberg, Adam J. Lamble, Jennifer Sheppard, Bonnie Yates, Alexandra E. Kovach, Brent L. Wood, Michael J. Borowitz, Marya...> ;Journal of Clinical Oncology. 2021 Nov 12
• 6 citations
  Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation.
  John C. Molina, Seth M. Steinberg, Bonnie Yates, Daniel W. Lee, Lauren Little, Crystal L. Mackall, Haneen Shalabi, Nirali N. Shah> ;Transplantation and Cellular Therapy. 2021 Oct 20
• 23 citations
  Infectious Complications of CAR T-Cell Therapy Across Novel Antigen Targets in the first 30 days.
  Lekha Mikkilineni, Bonnie Yates, Seth M. Steinberg, Shilpa A Shahani, John C Molina, Tara N. Palmore, Daniel W. Lee, Rosandra N. Kaplan, Crystal L. Mackall, Terry J. F...> ;Blood Advances. 2021 Oct 7
• 9 citations
  miR‑769‑5p is associated with prostate cancer recurrence and modulates proliferation and apoptosis of cancer cells
  Daniel Lee> ;Experimental and Therapeutic Medicine. 2021 Apr 1
• 140 citations
  Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.
  Nirali N. Shah, Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin, Pamela L. Wolters, Seth M. Steinberg, Eva H. Baker, Cindy Delbrook, Marya...> ;Journal of Clinical Oncology. 2021 Mar 25
• 125 citations
  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
  Marcela V. Maus, Sara Alexander, Michael R. Bishop, Jennifer N. Brudno, Colleen Callahan, Marco L. Davila, Claudia Diamonte, Jorg Dietrich, Julie C. Fitzgerald, Matthe...> ;Journal for Immunotherapy of Cancer. 2020 Dec 1
• 55 citations
  Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies.
  Haneen Shalabi, Vandana Sachdev, Amita Kulshreshtha, Julia W. Cohen, Bonnie Yates, Doug R Rosing, Stanislav Sidenko, Cindy Delbrook, Crystal L. Mackall, Brandon M. Wil...> ;Journal for Immunotherapy of Cancer. 2020 Sep 1
• 10 citations
  miR-484 is associated with disease recurrence and promotes migration in prostate cancer.
  Daniel Lee, Wei Tang, Tiffany H. Dorsey, Stefan Ambs> ;Bioscience Reports. 2020 May 29
• 10 citations
  Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvement.
  , , , , , , , , , , , , , , , > ;Pediatric Blood & Cancer. 2020 Jan 25
• 315 citations
  CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.
  Robbie G. Majzner, Johanna Theruvath, Anandani Nellan, Sabine Heitzeneder, Yongzhi Cui, Christopher Mount, Skyler P. Rietberg, Miles H. Linde, Peng Xu, Christopher Rot...> ;Clinical Cancer Research. 2019 Apr 15
• 1481 citations
  ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
  Daniel W. Lee, Bianca Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle, Jennifer N. Brudno, Marcela V. Maus, Jae H. Park, Elena Mead, Steven Z. Pavleti...> ;Biology of Blood and Marrow Transplantation. 2019 Apr 1
• 90 citations
  Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy.
  Lara L Riegler, Gavin P. Jones, Daniel W Lee> ;Therapeutics and Clinical Risk Management. 2019 Feb 28
• Join now to see all